eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
6/2008
vol. 3
 
Share:
Share:
abstract:

Fatty liver disease

Iwona Mikołajczyk
,
Mariusz Rosołowski
,
Aleksy Łukaszyk

Przegląd Gastroenterologiczny 2008; 3 (6): 276–282
Online publish date: 2009/01/16
View full text Get citation
 
Some individuals develop fatty liver disease. It is now well established that hepatic steatosis is frequently associated with obesity, insulin resistance and type 2 diabetes mellitus, or with excessive alcohol intake. Although clearly different in their metabolic origins, it is recognised that nonalcoholic and alcoholic fatty liver disease share several features and, most importantly, that accumulation of fat in the liver is not
a benign condition. Excess fat increases the vulnerability of hepatocytes to potential harmful effects of metabolic stress imposed by cytokines, viral infections and oxidative agents. As a consequence, hepatic steatosis is a factor predisposing to development of fibrosis and cirrhosis. This article reviews pathophysiology, diagnostic and therapeutic methods according to the currently recommended standards.
keywords:

fatty liver, nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, alcohol-induced liver disease, oxidative stress, metabolic syndrome

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.